|
1 Guzick D, Sullivan M, Adamson D, et al. Efficacy of treatment of unexplained infertility. Fertil Steril，1998，70(2)：207–213.
|
|
2 Christiansen OB, Nielsen HS, Kolte AM. Future directions of failed implantation and recurrent miscarriage research. Reprod Bio Med Online，2006，13(1)：71–83.
|
|
3 Berube S, Marcoux S, Langeoin M, et al. Fecundity of infertile women with minimal or mild endometriosis and women with unexplained infertility. Fertil Steril, 1998，69(6)：1034–1041.
|
|
4 Randolph F, Jr John MD. Unexplained infertility. Clin Obstet Gynecol，2000，43(4)：897–901.
|
|
5 Menken J，Trussell J，Larson U. Age and infertility. Science，1986，233：1389–1934.
|
|
6 Hull R，Glazener C, Kelly N, et al. Population study of causes，treatment and outcome of infertility.Br Med J，1985，291：1693–1697.
|
|
7 Coliins JA, Burrows EA, Willian AR. The prognosis for live birth among un–treated infertile couples. Fertil Steril, 1995，64：22–28.
|
|
8 The ASRM Practice Committee Educational Bulletin. Treatment of unexplained infertility. Am Societ Reprod Med, 2000，1–4.
|
|
9 Hughes E, Collins J, Vandekerckhove P. Clomiphene citrate for unexplained subfertility in women. Cochrane Database Syst Rev, 2000，(3)：CD000057.
|
|
10 Athaullah N, Proctor M, Johnson NP. Oral versus injectable ovulation induction agents for unexplained sub–fertility.Cochrane Database Syst Rev，2002，(3)：CD003052.
|
|
11 Collins J．Current best evidence for the advanced treatment of unexplained sub–fertility. Hum Reprod, 2003，18(5)：907–912.
|
|
12 Guzick DS, Carson SA, Coutifaris C, et al. Efficacy of super–ovulation and intrauterine insemination in the treatment of in–fertility. National Cooperative Reproductive Medicine Network. N Engl J Med，1999，340：177–183.
|
|
13 Zikopoulos K，West CP，Thong PW, et al. Homo–logous intra–uterine insemination has no advantage over timed natural intercourse when used in combination with ovulation induction for the treatment of unexplained infertility. Hum Reprod，1993，8：563–567.
|
|
14 Hughes EG. The effectiveness of ovulation induction and intrauterine insemination in the treatment of persistent infertility: A meta–analysis. Hum Reprod, 1997，12：1865–1872.
|
|
15 Cohlen BJ, Tevelde ER，Vankooij RJ, et al. Controlled ovarian hyperstimulation and intrauterine insemination for treating male sub–fertility：A controlled study. Hum Reprod，1998，13：1553–1558.
|
|
16 Zeyneloglu HB, Arici A, Olive DL，et al. Comparison of intra–uterine insemination with timed intercourse in superovulated cycles with gonadotropins：A meta–analysis. Fertil Steril，1998，69：486–491.
|
|
17 The ESHRE Capri Workshop ESHRE. Guidelines to the prevalence, diagnosis, treatment and management of infertility. Hum Reprod，1996，a(11)：1775.
|
|
18 The ESHRE Capri Workshop. Infertility revisited：The state of the art today and tomorrow. Hum Reprod，1996，b(11)：1779–1807.
|
|
19 Hughes EG. The effectiveness of ovulation induction and intrauterine insemination in the treatment of persistent infertility: A meta–analysis. Hum Reprod, 1997，12：1865–1872.
|
|
20 Goverde AJ, McDonnell J，Vermeiden JP, et al. Intrauterine insemination or in vitro fertilisation in idiopathic sub–fertility and male sub–fertility：A randomised trial and cost–effectiveness analysis. Lancet, 2000，355：13–18.
|
|
21 Philips Z, Barraza–Llorens M, Posnett J. Evaluation of the relative cost–effectiveness of treatments for infertility in the UK. Hum Reprod，2000，15：95–106.
|
|
22 Demiroll A，Gurgan T. Comparison of different gonadotropin preparations in intrauterine insemination cycles for the treatment of unexplained infertility：A pro–spective, randomized study. Hum Reprod，2007，22(1)：97–100.
|
|
23 Navot D. The value of in vitro fertilization for the treatment of unexplained infertility. Fertil Steril, 1988，49 (5)：854–857.
|
|
24 Crosignani P, Walters D, Soliani A. The ESHRE multicentre trial on the treatment of unexplained infertility. Hum Reprod Embryol，1991，6 (7)：953–958.
|
|
25 RCOG Infertility Guideline Group. The management of infertility in secondary care. BJU Int, 1999，83(6)：641–645.
|
|
26 Gurgan T, Urman B, Yarali H，et al. The results of in vitro fertilization–embryo transfer in couples with unexplained infertility failing to conceive with superovulation and intrauterine insemination. Fertil Steril，1995，64(1)：93–97.
|
|
27 Aboulghar M, Mansour RT, Serour GL, et al. Management of long–standing unexplained infertility：A prospective study. Am J Obstet Gynecol, 1999，181 (2)：371–375.
|
|
28 Pandian Z, Bhattacharya S, Vale L, et al. In vitro fertilisation for unexplained sub–fertility. Cochrane Database Syst Rev，2005，2：CD003357.
|
|
29 Hughes E, Collins J, Vandekerckhove P. Withdrawn: Bromocriptine for unexplained sub–fertility in women. Cochrane Database Syst Rev，2007，(4)：CD000044.
|
|
30 Hughes E, Brown J, Tiffin G, et al. Danazol for unexplained sub– fertility (Systematic Review)．Cochrane Menstrual Disorders and Sub–fertility Group. Cochrane Database Syst Rev, 2007，(1)：CD000069.
|
|
31 Vandekerckhove P, Watsan A, Lilford R, et al. Oil–soluble versus water soluble media for assessing tubal patency with hystero–salpingography or laparoscopy in sub–fertile women. Cochrane Database Syst Rev，2007，(4)：CD000092.
|
|
32 Collins JA. An international survey of the health economics of IVF and ICSI.Hum Reprod Update，2002，8(3)：265–277.
|
|
33 Chaplin R, Earl L. Household spending on health care. Health Report (Statistics Canada, Catalogue 82–003)，2000，12：57–65.
|